Protalix Announces Data on Oral antiTNF to be Presented at Digestive Disease Week 2014 Meeting
April 23, 2014 at 08:33 AM EDT
Protalix BioTherapeutics, Inc. (NYSE: PLX) (TASE:PLX), announced today that preclinical data on oral antiTNF (PRX-106) was accepted for ...